ClinicalTrials.Veeva

Menu
C

CT Clinical Research | Cromwell, CT

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

JZP150
BI 1569912
Cariprazine
Dasotraline
Pimavanserin
Zavegepant
BHV-3500
Quetiapine
Simufilam
BI 1358894

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 15 total trials

A Study to Test Different Doses of BI 1569912 in People With Depression Who Take Anti-depressive Medicine

This study is open to adults between 18 and 65 with a type of depression (major depressive disorder) for whom previous treatments for depression did...

Enrolling
Depressive Disorder, Major
Drug: BI 1569912
Drug: Placebo

The purpose of this study is to test the long-term safety of rimegepant in the acute treatment of migraine in children and adolescents (≥ 6 to \< 18...

Enrolling
Acute Treatment of Migraine
Drug: Rimegepant (PF-07899801)

The purpose of this study is to test the safety and efficacy of BHV-3000 versus placebo in the acute treatment of moderate or severe migraine in chil...

Enrolling
Pediatric Migraine
Drug: Rimegepant/BHV3000
Drug: Matching placebo

Trial sponsors

Pfizer logo
AbbVie logo
Boehringer Ingelheim logo
Acadia Pharmaceuticals logo
C
Jazz Pharmaceuticals logo
Purdue Pharma logo
Sumitomo Pharma logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems